Mirum Pharmaceuticals (MIRM) EBT: 2020-2025
Historic EBT for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $2.6 million.
- Mirum Pharmaceuticals' EBT rose 119.03% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.8 million, marking a year-over-year increase of 58.33%. This contributed to the annual value of -$86.9 million for FY2024, which is 46.49% up from last year.
- According to the latest figures from Q3 2025, Mirum Pharmaceuticals' EBT is $2.6 million, which was up 148.42% from -$5.5 million recorded in Q2 2025.
- Over the past 5 years, Mirum Pharmaceuticals' EBT peaked at $57.3 million during Q4 2021, and registered a low of -$73.7 million during Q2 2023.
- Over the past 3 years, Mirum Pharmaceuticals' median EBT value was -$24.0 million (recorded in 2024), while the average stood at -$24.2 million.
- Per our database at Business Quant, Mirum Pharmaceuticals' EBT spiked by 253.56% in 2021 and then slumped by 163.34% in 2022.
- Quarterly analysis of 5 years shows Mirum Pharmaceuticals' EBT stood at $57.3 million in 2021, then slumped by 163.34% to -$36.3 million in 2022, then increased by 2.36% to -$35.4 million in 2023, then spiked by 31.24% to -$24.4 million in 2024, then skyrocketed by 119.03% to $2.6 million in 2025.
- Its EBT stands at $2.6 million for Q3 2025, versus -$5.5 million for Q2 2025 and -$13.6 million for Q1 2025.